Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers

Y Xie, W Kuang, D Wang, K Yuan, P Yang - European Journal of Medicinal …, 2023 - Elsevier
CXC motif chemokine receptor 2 (CXCR2) is G protein-coupled receptor (GPCR) and plays
important roles in various inflammatory diseases and cancers, including chronic obstructive …

[HTML][HTML] Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases

H Ha, B Debnath, N Neamati - Theranostics, 2017 - ncbi.nlm.nih.gov
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation
and trafficking of inflammatory mediators as well as tumor progression and metastasis. The …

CXCR4 receptor as a promising target for oncolytic drugs

Y Lavrovsky, YA Ivanenkov, KV Balakin… - Mini Reviews in …, 2008 - benthamdirect.com
There has been considerable in vivo evidence that chemokine receptor CXCR4 and its
endogenous ligand CXCL12 modulate some important physiological and …

CXCR2 receptor antagonists: a medicinal chemistry perspective

MP Dwyer, Y Yu - Current Topics in Medicinal Chemistry, 2014 - ingentaconnect.com
Dysregulated leukocyte recruitment is believed to be a key contributor to various acute and
chronic inflammatory disorders which can lead to serious pathological consequences …

CXCR2 chemokine receptor–a master regulator in cancer and physiology

G Lazennec, K Rajarathnam, A Richmond - Trends in Molecular Medicine, 2024 - cell.com
Recent findings have modified our understanding of the roles of chemokine receptor CXCR2
and its ligands in cancer, inflammation, and immunity. Studies in Cxcr2 tissue-specific …

Towards small‐molecule CXCR3 ligands with clinical potential

M Wijtmans, D Verzijl, R Leurs… - ChemMedChem …, 2008 - Wiley Online Library
The CXCR3 chemokine receptor was first discovered in 1996 and has been shown to play
an important role in several diseases, most of which are related to inflammation. This review …

CXCR3 ligands in disease and therapy

K Van Raemdonck, PE Van den Steen… - Cytokine & growth factor …, 2015 - Elsevier
Chemokines, binding their various G protein-coupled receptors, lead the way for leukocytes
in health and inflammation. Yet chemokine receptor expression is not limited to leukocytes …

CXCR4/CXCL12 axis:“old” pathway as “novel” target for anti‐inflammatory drug discovery

L Lu, J Li, X Jiang, R Bai - Medicinal Research Reviews, 2024 - Wiley Online Library
Inflammation is the body's defense response to exogenous or endogenous stimuli, involving
complex regulatory mechanisms. Discovering anti‐inflammatory drugs with both …

CXCR2: from bench to bedside

A Stadtmann, A Zarbock - Frontiers in immunology, 2012 - frontiersin.org
Leukocyte recruitment to sites of infection or tissue damage plays a crucial role for the innate
immune response. Chemokine-dependent signaling in immune cells is a very important …

The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential

D Peng, B Cao, YJ Zhou, YQ Long - European journal of medicinal …, 2018 - Elsevier
The CXC chemokine receptor 4 (CXCR4) is a highly reserved G-protein coupled 7-
transmembrane (TM) chemokine receptor which consists of 352 amino acids. CXCR4 has …